SCHEMBL7862276

SCHEMBL7862276

CCCCC1=NCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL168016 0.94 HTR1D (0.57)
SCHEMBL5680179 0.92 HTR1D (0.56)
SCHEMBL1626311 0.92 HTR1D (0.56)
SCHEMBL7756299 0.92 HTR1D (0.56)
SCHEMBL5675527 0.92 HTR1D (0.56)
SCHEMBL2845525 0.92 HTR1D (0.56)
Propane SCHEMBL9444503 0.92 HTR1D (0.56)
SCHEMBL15561019 0.92 HTR1D (0.56)
SCHEMBL1736375 0.92 HTR1D (0.56)
SCHEMBL107099 0.92 HTR1D (0.56)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0625969-B1 ARYLALKOXYPHENOXY-IMIDAZOLINE COMPOUNDS MERRELL PHARMA INC (US) 2001-03-07 EP claimed
WO-2023183394-A1 ALPHA 1A-ADRENERGIC RECEPTOR AGONISTS AND METHODS OF USE CURASEN THERAPEUTICS, INC. (US) 2023-09-28 WO disclosed
US-20230062712-A1 ANTI-ASGR1 ANTIBODY CONJUGATES AND USES THEREOF SILVERBACK THERAPEUTICS, INC. 2023-03-02 US disclosed
US-11566015-B2 Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof Crinetics Pharmaceuticals, Inc. (US) 2023-01-31 US disclosed
US-11541126-B1 Anti-ASGR1 antibody TLR8 agonist comprising conjugates and uses thereof SILVERBACK THERAPEUTICS, INC. (US) 2023-01-03 US disclosed
US-20220152215-A1 Immunoconjugates Targeting CEA BOLT BIOTHERAPEUTICS, INC. (US) 2022-05-19 US disclosed
CN-114096377-A Flux, rosin-cored solder using flux, flux-coated solder using flux, and soldering method 千住金属工业株式会社 2022-02-25 CN disclosed
US-20210238164-A1 MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF Crinetics Pharmaceuticals, Inc. 2021-08-05 US disclosed
US-20210002254-A1 MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF Crinetics Pharmaceuticals, Inc. 2021-01-07 US disclosed
US-20200216415-A1 MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF Crinetics Pharmaceuticals, Inc. 2020-07-09 US disclosed
US-20150158970-A1 LIQUID HARDENERS FOR HARDENING EPOXIDE RESINS (II) ALZCHEM AG (DE) 2015-06-11 US disclosed
US-20150158972-A1 LIQUID HARDENERS FOR HARDENING EPOXIDE RESINS (I) ALZCHEM AG (DE) 2015-06-11 US disclosed
EP-2880072-A2 LIQUID HARDENERS FOR HARDENING EPOXIDE RESINS (II) AlzChem AG (DE) 2015-06-10 EP disclosed
WO-2014020072-A2 LIQUID HARDENERS FOR HARDENING EPOXIDE RESINS (II) ALZCHEM AG (DE) 2014-02-06 WO disclosed
US-20080171769-A1 Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders CHEMBRIDGE CORPORATION 2008-07-17 US disclosed
US-7301037-B2 Charged compounds comprising a nucleic acid binding moiety and uses therefor GENESOFT, INC. (US) 2007-11-27 US disclosed
US-20070105135-A1 Charged compounds comprising a nucleic acid binding moiety and uses therefor GENESOFT PHARMACEUTICALS, INC. (US) 2007-05-10 US disclosed
EP-0331507-B1 POLYVINYL CHLORIDE PLASTISOL COMPOSITION ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) 1993-05-19 EP disclosed
US-4977201-A Blended with modified epoxy resin, blocked isocyanate, latent curing for resin as tackifier, automobile undercoatings ASAHI DENKA KOGYO K.K. (JP) 1990-12-11 US disclosed
EP-0331507-A1 Polyvinyl chloride plastisol composition ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) 1989-09-06 EP disclosed